American Oncology Network, Inc.: M&A transaction — American Oncology Network acquires Central Georgia Cancer Care for $13.3M total consideration

American Oncology Network, Inc.

Cash consideration of $4.6M, $6.4M promissory note (60-month monthly payments), and ~$2.3M for inventory.
CGCC provides cancer and blood disorder treatment at two locations in Macon and Warner Robins, GA.
CGCC reported 2023 patient service revenue of approximately $71.9M, primarily from visit-based and pharmacy revenue.
AON issued a $6.4M promissory note; monthly payments of $106,667 plus interest at variable cost of borrowing.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

American Oncology Network, Inc. completed an acquisition involving Central Georgia Cancer Care, P.C. (closed 2024-04-01).

Action: acquisition
Counterparty: Central Georgia Cancer Care, P.C.
Closing: 2024-04-01

Exact text from the filing

On April 1, 2024, consolidated subsidiaries of American Oncology Network, Inc. (“AON” or the “Company”) acquired certain clinical and non-clinical assets of Central Georgia Cancer Care, P.C., (“CGCC”) from the CGCC shareholders for consideration consisting of (i) a cash payment in the amount of $4.6 million, (ii) a promissory note in the amount of $6.4 million under which the terms require principal and interest payments in monthly installments over 60 months commencing May 1, 2024, and (iii) a cash payment of approximately $2.3 million for acquired inventories, (the “CGCC Acquisition”).

View on SEC.gov

Browse all m&a transactions →

Source: SEC EDGAR

accession 0001628280-24-052081

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.